April 19, 2022
1 min watch
Save
Video: New guidelines help relabel heart failure
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, David E. Lanfear, MD, MS, FHFSA, advanced HF specialist and program director of the Advanced Heart Failure Fellowship at the Henry Ford Health System in Detroit, discusses the new HF guidelines presented at the American College of Cardiology Scientific Session.
The new guidelines followed a new definition of HF presented at last year’s ACC, and “changes a lot in terms of how we define heart failure and the labeling that we put on it,” according to Lanfear.
Lanfear said the guidelines also provide clarifications on new drug therapies.
Reference:
- Heidenreich et. al. AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Presented at: American College of Cardiology Scientific Session & Expo 2022; April 2-4, 2022; Washington, D.C.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Lanfear reports receiving research grants from and consulting or serving on an advisory board for Amgen, receiving research grants from Somalogic and consulting or serving on an advisory board for Abbott, Cytokinetics, DCRI, Janssen, Martin and Ortho Diagnostics.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.